The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis.

about

The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis.

Item

http://www.wikidata.org/entity/Q52584784

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The prevalence of the metaboli ...... replacement: a KIMS analysis.

@en

The prevalence of the metaboli ...... replacement: a KIMS analysis.

@nl

type

Item

label

The prevalence of the metaboli ...... replacement: a KIMS analysis.

@en

The prevalence of the metaboli ...... replacement: a KIMS analysis.

@nl

prefLabel

The prevalence of the metaboli ...... replacement: a KIMS analysis.

@en

The prevalence of the metaboli ...... replacement: a KIMS analysis.

@nl

P1476

The prevalence of the metaboli ...... replacement: a KIMS analysis.

@en

P2093

Anders F Mattsson

http://www.w3.org/2001/XMLSchema#string

Anton Luger

http://www.w3.org/2001/XMLSchema#string

Cecilia Camacho-Hübner

http://www.w3.org/2001/XMLSchema#string

Johan Verhelst

http://www.w3.org/2001/XMLSchema#string

Roger Abs

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency.

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database).

Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study.

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.

The metabolic syndrome--from insulin resistance to obesity and diabetes.

Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes.

P304

653-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EC-18-0096

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29661785

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

5952245

http://www.w3.org/2001/XMLSchema#string